Download to read offline
More Related Content
Similar to Anti-Microbials Cell Wall Synthesis Inhibitors
Anti-Microbials Cell Wall Synthesis Inhibitors
- 1. BETA LACTAM ANTIBIOTICSAND OTHER INHIBITORS OF CELL WALL SYNTHESIS Penicillins Cephalosporins Monobactams Carbapenems
- 2. Penicillin G Penicillin V Methicillin Oxacillin Nafcillin Cloxacillin Dicloxacillin Ampicillin Piperacillin Ticarcillin Carbenicillin Amoxycillin Mezlocillin Azlocillin Penicillins Cefazolin Cefadroxil Cephalexin Cephalothin Cephradine Cephapirin 1stgeneration Cefaclor Cefamandole Cefonicid Cefametazole Cefotetan Cefoxitin Cefuroxime 2nd generation Cefdinir Cefixime Cefoperazone Cefotaxime Ceftazidime Moxalactam Ceftriaxone Ceftibuten Ceftizoxime 3rd generation Cefepime 4th generation Cephalosporins Imipenams/Cilastatin Carbepenams Aztreonam Monobactams Beta lactam antibiotcs Vancomycin Bacitracin Other antibiotics INHIBITORS OF CELL WALL SYNTHESIS
- 3. Penicillins • First antibioticto be used clinically. • Alexander Fleming – 1929. • First penicillins from cultures of Penicillium notatum( fungus ) in 1941-Chain & Florey. • Presently from cultures of Penicillium chrysogenum.
- 4. • Basic structureof Penicillin consists of a Thiazolidine ring (A) fused to a Beta lactam ring (B) to which side chains (R) are attached through an amide linkage.
- 5. • In Naturalpenicillin, Pn G, R- side chain is a benzyl side chain • But in semisynthetic penicillins R is anything other than benzyl moiety.
- 6. 6 Penicillin Structural Features& Requirements for Antibacterial Activity
- 7. 7 • Moieties Aand B together constitute the 6- aminopennicillanic acid nucleus. • The penicillin nucleus is the chief structural requirement for antibacterial activity. • Side chain determines many of the antibacterial and pharmacological characteristics of a particular type of penicillin.
- 8. • Several typesof natural penicillins – F, G , X , & K. – PnG (benzyl penicillin) •Greatest antimicrobial activity •Only natural penicillin used clinically. • Na & K salts more stable.
- 9. UNITAGE OF PENICILLIN •Activity of natural penicillins (Pn G) is described in units – Crystalline sod Pn G contains 1600 units /mg. – 1 unit of PnG =o.6 Ug – Or, 600 mg of Pn G = 1 million units • Semi synthetic penicillins are prescribed by weight – Amox 500 mg 8 hrly orally
- 10. • 1 mg= 1600 units • 1600 units = 1 mg • 1 unit = 0.6 Ug • 0.6 Ug = 1 unit • 6 Ug = 10 unit • 6000 Ug = 10,000 units • 6 mg = 10,000 units • 600 mg = 10,000,00 units
- 11. 11 Mechanism of action •All β lactam antibiotics interfere with the synthesis of bacterial Cell wall
- 12. • Bacteria aresurrounded by a thick cell wall that confers stability & rigidity to their cell structure • Cell wall is composed of peptide chains & glycan chains • Extensively cross linked • Peptidoglycan layer envelops the cell & does not allow bacteria to swell & prevent death due to lysis
- 13. 13 Bacterial Cell WallSynthesis • Glycan chains consist of two aminosugars – N acetyl muramic acid (NAM) & – N acetyly glucosamine (NAG) • Pentapeptide side chain is linked to NAM sugar • Forms the peptidoglycan molecule • Peptidoglycan residues are linked together and UDP is split off
- 14. • Final stepis cleavage of terminal D alanine of the peptide chains by transpeptidases • Catalyzed by PBPs, transmembrane surface enzymes present in bacteria • Energy is released which is utilized for establishing cross linkages between peptide chains of the neighbouring strands. • This cross linking Provides stability and rigidity to the cell wall
- 15. 15 Mechanism of action •Penicillins inhibit bacterial cell wall synthesis • Inhibit the PBPs catalysed process of transpeptidation – cross linking (maintains close knit structure of bacterial cell wall) does not occur • Last step in peptidoglycan synthesis
- 16. • When susceptiblebacteria divide in the presence of β lactam antibiotic cell wall deficient forms are produced. • Interior of bacterium is hyperosmotic • Osmotic drive occurs • CWD form swell and bursts • Lysis of bacteria- BACTERICIDAL
- 17. • Lytic effectmay also be due to derepression of some bacterial autolysins. • Rapid cell wall synthesis occur when organisms are actively multiplying. – Beta lactam antibiotics are more lethal in this phase.
- 18. – Peptidoglycan cellwall is unique to bacteria. – No such substance is synthesized by higher animals. Penicillins are practically non toxic to man.
- 19. • G +vebacteria – Cell wall is entirely made of peptidoglycan. – Cell wall is 50-100 layers thick – Extensively cross linked and – May be considered as a single giant peptide molecule, – The peptidoglycan layer is easily accessible to β - lactam antibiotics – Inhibition of transpeptidation reaction becomes easier
- 20. • G -vebacteria – Have two membranes – Outer membrane – Inner membrane – Peptidoglycan sandwiched b/w the two – Outer membrane consists of lipopolysaccharides with narrow porin channels ; • barrier to β-lactam antibiotics • Hence weaker activity Reason for higher susceptibility of g +ve bacteria to Pn G
- 21. 21 Gram-positive Bacterial Membrane Structure Thelipid bi- layer cell membrane of most of the Gram-positive bacteria is covered by a porous peptidoglycan layer Peptidoglyc an cell wall Cytoplasmic Membrane d d
- 22. 22 Gram-negative Bacterial Membrane Structure •Gram-negative bacteria are surrounded by two membranes. • The outer membrane functions as an efficient permeability barrier containing lipopolysaccharides (LPS) and porins. Outer membrane Peptidoglycan cell wall Cytoplasmic membrane d d d
- 23. • Penicillins withhydrophillic character , Ampicillin & amoxycillin can diffuse through these porin channels ; • show activity against some gram- negative bacteria also • but not against psuedomonas aeruginosa because these bacteria lack in such classical permeable porin channels.
- 24. Resistance Inherent Gram -ve bacteriaare inherently insensitive Deeper localisation of target enzymes & penicillin binding protein. loss or alteration of porin channels ; Pn G is unable to penetrate. Acquired: Production of penicillinase.
- 25. PENICILLINASE opens the βlactam ring and inactivates Pn G Staphylococcus, Gonococcus, B subtilis, E coli, H influenzae produce penicillinase.
- 26. Penicillinase Gram +ve organisms producelarge quantity of penicillinase which diffuse in the surroundings and protect the bacteria. In Gram -ve bacteria constitutive enzyme small quantity strategically located between the lipoprotein and peptidoglycan layers of the cell wall.
- 27. 27 PBP’s : Penicillin Binding Proteins Gram –vebacteria Gram +ve bacteria
- 28. • Efflux pumpin some G -ve bacteria.
- 29. 29 Penicillin G • NaturalPenicillin • Narrow spectrum • Primarily active against G +ve bacteria –Few gram negative & anaerobes
- 30. Antibacterial spectrum : •G +ve Cocci : streptococci are highly sensitive • So are pneumococci • S. aureus- >90% have acquired resistance. • Gram +ve Bacilli : B. anthrasis, C. diphtheria, all Clostridia, Listeria are highly sensitive. • Gram -ve cocci: • N. gonorrhoe (Highly resistant), • N. meningitides are susceptible to Pn G. • G –ve bacilli , Myco TB rickettsia, chlamydia, protozoa, fungi & viruses are totally unresponsive.
- 31. • Most anaerobicmicroorganisms including clostridium species are highly sensitive. • So are spirochaetes (T. pallidum, Leptospira and others)
- 32. • Strepto • Pneumo •Meningo • Anaerobes • Spirochaetes
- 33. Pharmacokinetics: •Acid labile -destroyedby gastric acid. •Absorption from IM site is rapid, reaches most body fluids •Plasma half life is 30 minutes. •To prolong the duration of action:
- 34. excreted by rapidrenal excretion. –10 % by GF; 90 % TS. –TS is blocked by Probenecid, higher and long lasting plasma concentrations are achieved. –Rarely used for this purpose –Repository preparations are used »Pencillin G procaine »Pencillin G benzathine
- 35. • Release penicillinslowly from the area in which they are injected & produce relatively low but persistent concentrations of antibiotics in the blood.
- 36. Preparations: • Penicillin G(Sodiumpenicillin G (crystalline)/ benzyl penicillin). • Procaine penicillin G. • Bezathaine penicillin G. • Fortified Procaine penicillin G.
- 37. Therapeutic Uses : •Streptococcal infections. –DOC for sensitive strains • Pneumococcal. –Used for senstive strains –Replaced by third generation cephalosporins. • Meningococcal. • Gonorrhoea- not reliable, • Syphylis- drug of choice, • Diphtheria- for carrier state. • Tetanus and gas gangrene.
- 38. Infections with Anaerobes •Periodontal infections usually respond well to penicillin G. – Mild-to-moderate infections at these sites may be treated with oral medication (either penicillin G or penicillin V 400,000 units four times daily). – More severe infections should be treated with 12 million to 20 million units of penicillin G intravenously.. • Necrotising gigivitis • Vincents angina
- 39. Prophylactic use : •Rheumatic fever – 1.2 million units , im, once a month, lifelong in high risk people. • Bacterial endocarditis - caused by dental extractions, endoscopies, catheterization, etc. cause bacteremia which in patients with valvular defects can cause endocarditis.
- 40. INFECTIVE ENDOCARDITIS • Somecases of endocarditis occur after dental procedures. • Prophylactic antibiotics are given to patients with predisposing congenital or valvular anomalies.
- 41. Endocarditis prophylaxis recommended •Prosthetic cardiac valves • Previous BE • Congenital heart diseases. – unrepaired cyanotic CHD – Completely repaired CHD with prosthetic material / device. • Cardiac transplantatiom recipients in whom cardiac valvulopathy developes. AHA - 2007
- 42. Dental procedures forwhich: Endocarditis prophylaxis recommended All dental procedures thast involve manipulation if gingival tissue or the periapical region of the teeth or perforation of the oral mucosa. • Dental extractions. • Periodontal procedures. • Dental implant replacement or reimplantation. • Initial placement of orthodontic bands but not brackets. • Prophylactic cleaning of teeth or implants where bleeding is anticipated. Endocarditis prophylaxis not recommended • Restorative dentistry (filling cavities, operative & prosthodontics) with or without retraction cord. • LA injections • Postoperative suture removal. • Taking of oral impressions. • Fluoride treatment. • Orthodontic appliance adjustment.
- 43. ENDOCARDITIS PROPHYLAXIS ROUTE DOCDOSE ORAL Penicillin allergy AMOXICILLIN 2 g; 1 hr before procedure CLINDAMYCIN, OR CEPHALEXIN OR AZITHROMYCIN / CLARITHROMYCIN 600 mg; 1 hr before procedure 2 g; 1 hr before procedure 500 mg; 1 hr before procedure PAREN TERAL Penicillin allergy AMPICILLIN 2 g IM or IV; 30 minutes before procedure 600 mg IV; 1 hr before procedure 1 g IM or IV; 30 minute before procedure CLINDAMYCIN OR CEFAZOLIN
- 44. Semisynthetic penicillins: Chemically combining specific side chainin place of benzyl side chain. Aim is to overcome the short comings of Penicillin G. Narrow spectrum Poor oral efficacy Susceptibility to penicillinase Hypersensitivity (has not been overcome in any preparation).
- 45. • Acid resistantalternative to Pn G: • Phenoxymethyl penicillin (Penicillin V) • Penicillinase resistant penicillin: • Cloxacillin • Methicillin • Extended spectrum penicillins: • Aminopenicillins – Ampicillin – Bacampicillin – Amoxycillin • Carboxypenicillins – Carbenicillin, – Ticarcillin. • Ureidopenicillins – Mezlocillin, – Piperacillin.
- 46. Phenoxymethyl penicillins: (PnV) • It differs from Pn G only in that it is acid stable • Oral absorption is better • Antibacterial spectrum is identical to penicillin G. Less active against Neisseria & other gram -ve bacteria & anaerobes. • Not dependable in serious conditions. • Primarily for streptococcal infections like pharyngitis, sinusitis, otitis media, prophylaxis of rheumatic fever. Dose: 250-500 mg 6 hrly. 250 mg= 4 lac unit.
- 47. Penicillinase resistant penicillins: •Have side chains that protect the beta lactam ring from attack by staphylococcal penicillinase. • Their only indication is infection caused by penicillinase producing staphylococci infection for which they are drug of choice.
- 48. Cloxacillin: –Highly penicillinase &Acid resistant. –Can be given orally. –Effective against penicillinase producing bacteria. –Dose: 250-500 mg 6 hrly. Oxacillin dicloxacillin flucloxacillin are similar (not available in India).
- 49. Methicillin: –Highly penicillinase butnot Acid resistant. –Must be injected i.v –MRSA have emerged in many areas –These are insensitive to penicillinase resistant penicillins / other B lactams & erythromycin/ aminoglycosides/ tetracyclines etc. –Have altered PBPs ; do not bind penicillins –DOC Vancomycin/ linezolid/ ciprofloxacin can also be used. –Nephrotoxicity
- 50. Extended spectrum penicillins: •Active against wide variety of gram –ve bacteria as well. X Psuedomonas, kleibseilla, proteus (lack porin channels) Aminopenicillins : • Amino substitution in the side chain Ampicillin • Active against all organisms as penicillin G + many gram –ve bacteria(Hydrophillic; penetrate porin chanels). – H.influenzae, E.coli, Proteus, Salmonella, and Shigella. – Many have developed resistance.
- 51. • Pharmacokinetics: –oral absorption-incompletebut adequate. – Food interferes with absorption, I hour before meals.(X amoxycillin) –primary channel kidney. • Dose: 0.5-2gm oral/IM/IV 6 hrly.
- 52. Adverse effects : Diarrhoea •Unabsorbed drug irritates the lower intestines. • Alteration of normal bacterial flora. Rashes
- 53. Bacampicillin • Prodrug ofampicillin • Completely absorbed. – Does not disturb intestinal ecology. – Incidence of diarrhoea is less • Higher plasma levels are obtained. • Better tissue penetration Talampicillin Pivampicillin Hetacillin • Are other prodrugs of ampicillin.
- 54. Amoxycillin : Congener ofampicillin Similar in all respects except: »Oral absorption is better. »Food does not interfere. »Higher & more sustained blood levels. »Incidence of diarrhoea is less. »Less active against shigella & H.influenzae. • Dose : 0.25-1 gm TDS oral/IM.
- 55. Aminopenicillins Therapeutic Uses: • Indentistry: Ampicillin/ Amoxicillin is used alone or with metranidazole in – acute necrotising ulcerative gingivitis – or peridontitis – pulpitis, – dentoalveolar abcess, – ludwig’s Angina, – osteomyelitis of mandible etc • UTI/RTI/Meningitis/Gonorrhoea/Typhoid fever/Bacillary dystentry/ • Cholecystitis/SABE/Septicemia & mixed infections.
- 56.
- 57. Carbenicillin Comparable activityagainst many gram positive & -ve organisms. Special feature of this penicillin congener is its activity against Pseudomonas auerginosa and indole positive Proteus which are not inhibited by Pn G or aminopenicillins. Neither penicillinase nor acid resistant Inactive orally ; P/E administration.
- 58. Used as: 1-5 gm IV 4-6 hrly. and excreted in urine. C/I : in renal patients. Indications: Serious infections caused by Pseudomonas or Proteus eg. Burns, UTI, Septicemia. Piperacillin is now preferred.
- 59. Ticarcillin • More potentthan carbenicillin. • Other properties are similar to carbenicillin.
- 60. Ureidopenicillins : Piperacillin • ThisAntipseudomonal penicillin is 8 times more active than carbenicillin. • Good activity against Klebsiella. • Dose: 3-4 gm 6-8 hrly. • It is available in combination with Tazobactam.
- 61. Piperacillin in combinationwith beta lactamase inhibitor (zosyn) • has the broadest antibacterial spectrum amongst the penicillins. • High billiary concentrations are achieved. • Important agent for the treatment of patients with serious infections caused by psuedomonas, proteus & klebseilla – Bacteremias – pneummonias – and infections following burns and UTIs – Pseudomonas infection in neutropenic/ immunocompromised patients .
- 62. Adverse reactions topenicillins •Pain & sterile inflammatory reactions at the sites of i.m injection. •Phlebitis & thrombophlebitis on i.v injection. •Nausea with / without vomiting. •Mild to severe diarrhoea. •mental confusion, muscular twitchings, convulsions, coma. •Procaine penicillin: hallucinations, convulsions.
- 63. •Hypersensitivity reactions: incidence 1-10%.,rash, itching, urticaria & fever acute anaphylactic reactions. –History –Senstivity test –Inj adrenaline & hydrocortisone handy •Jarisch Herxheimer Reaction.
- 64. β - Lactamaseinhibitors
- 65. β lactamases • Familyof enzymes produced by g-ve & g+ve organisms • Inactivate β lactam antibiotics by opening the β lactam ring
- 66. β -lactamase inhibitors •Potent inhibitors of β -lactamases • Resemble β -lactam antibiotic • Do not possess antimicrobial action
- 67. • Bind irreversiblyto the catalytic site of susceptible β -lactamases particularly penicillinase to prevent hydrolysis of penicillins • Suicide inhibitors
- 68. Clavulanic acid SulbactamTazobactam Beta lactamase Inhibitors Currently 3 ß-lactamase inhibitors are available
- 69. –Clavulanic acid, ORAL/PARENTRAL derivedS. clavuligerus –Sulbactam I.M/I.V semisynthetic, –and tazobactam I.M/I.V str. analogue of sulbactam
- 70. • These agentsare given together with hydrolyzable penicillins to protect them from inactivation. • Extends the use of penicillin against β - lactamase producing bacteria. • ACCORDING TO THEIR COMMON pK features – Clavulanic acid + amoxacillin – Sulbactam + ampicillin – Tazobactam + piperacillin & are available as fixed dose combinations
- 71. –Clavulanic acid 125mg + amoxacillin 250mg –Sulbactam 0.5g + ampicillin 1g –Tazobactam 0.25g +piperacillin 2g available as fixed dose combinations
- 72. Most effective againstβ-lactamases produced by: • Staphylococci • H. influenzae • N. gonorrhoeae • Salmonella • Shigella • E. coli • K. pneumoniae
- 73. • The β-lactamase inhibitors are effective against ß-lactamase producing organisms. – e.g. ampicillin in combination with sulbactam is effective against ß-lactamase producing S. aureus and H. influenzae. • Non β - lactamase producing micro- organisms : no advantage • Ineffective against Methicilin resistant staph aureus.
- 74. THERAPEUTIC USES • Sulbactamis used in Odontogenic infections caused by β-lactamase producing strains of Staph. Aureus, H. influenzae E. coli, N. gonorrhoeae, Salmonella, Shigella. • Mixed nosocomial infections. • Skin & Soft tissue infection, • Urinary, biliary and respiratory tract infection, • Mixed intra-abdominal and pelvic infections, • Hospital acquired infection.
- 75.
- 76. 76 Mechanism of action •Cell wall of bacteria essential for normal growth &development • Peptidoglycan • Highly cross linked latticework structure • Glycan chains (linear strands of two aminosugars; NAG NAM) cross linked by peptide chains • Provides rigid mechanical stability
- 77. Endocarditis prophylaxis notrecommended • Surgical repair of – ASD, VSD – PDA • Previous CABG • MVP without valvular regurgitation. • Physiologic, functional or innocent heart murmurs. • Previous rheumatic fever without valvular dysfunction. • Cardiac pacemakers (intravascular & epicardial) & implanted defibrillators.